carmustine has been researched along with Lung Diseases, Interstitial in 4 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A decreased incidence of interstitial pneumonitis as well as a possible benefit in efficacy has been reported with lomustine (CCNU) compared to BCNU in the standard dose setting." | 2.70 | Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease. ( Blume, KG; Chao, NS; Horning, SJ; Johnston, LJ; Long, GD; Negrin, RS; Shizuru, JA; Stockerl-Goldstein, KE; Stuart, MJ; Wong, RM, 2001) |
| "We report a fatal case of acute interstitial pneumonitis in a patient treated with carmustine (BCNU) for a brain tumor." | 1.29 | Severe diffuse interstitial pneumonitis induced by carmustine (BCNU). ( Delaval, P; Desrues, B; Le Coz, A; Lena, H; Quinquenel, ML, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chastagner, P | 1 |
| Kalifa, C | 1 |
| Doz, F | 1 |
| Bouffet, E | 1 |
| Gentet, JC | 1 |
| Ruchoux, MM | 1 |
| Bracard, S | 1 |
| Desandes, E | 1 |
| Frappaz, D | 1 |
| Klingemann, HG | 1 |
| Shepherd, JD | 1 |
| Reece, DE | 1 |
| Barnett, MJ | 1 |
| Nantel, SH | 1 |
| Sutherland, HJ | 1 |
| Spinelli, JJ | 1 |
| Phillips, GL | 1 |
| Lena, H | 1 |
| Desrues, B | 1 |
| Le Coz, A | 1 |
| Quinquenel, ML | 1 |
| Delaval, P | 1 |
| Stuart, MJ | 1 |
| Chao, NS | 1 |
| Horning, SJ | 1 |
| Wong, RM | 1 |
| Negrin, RS | 1 |
| Johnston, LJ | 1 |
| Shizuru, JA | 1 |
| Long, GD | 1 |
| Blume, KG | 1 |
| Stockerl-Goldstein, KE | 1 |
1 review available for carmustine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategies.
Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Tr | 1994 |
2 trials available for carmustine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Outcome of children treated with preradiation chemotherapy for a high-grade glioma: results of a French Society of Pediatric Oncology (SFOP) Pilot Study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chemotherapy, Adjuvan | 2007 |
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Pro | 2001 |
1 other study available for carmustine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Severe diffuse interstitial pneumonitis induced by carmustine (BCNU).
Topics: Acute Disease; Adult; Brain Neoplasms; Carmustine; Fatal Outcome; Humans; Lung Diseases, Interstitia | 1994 |